These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 16207594)
1. The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells. Sun J; Huang H; Zhu Y; Lan J; Li J; Lai X; Yu J Int J Hematol; 2005 Oct; 82(3):215-23. PubMed ID: 16207594 [TBL] [Abstract][Full Text] [Related]
2. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843 [TBL] [Abstract][Full Text] [Related]
3. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621 [TBL] [Abstract][Full Text] [Related]
4. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890 [TBL] [Abstract][Full Text] [Related]
5. A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation. Pendino F; Sahraoui T; Lanotte M; Ségal-Bendirdjian E Leukemia; 2002 May; 16(5):826-32. PubMed ID: 11986943 [TBL] [Abstract][Full Text] [Related]
6. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. Duprez E; Lillehaug JR; Gaub MP; Lanotte M Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786 [TBL] [Abstract][Full Text] [Related]
7. [Effects of interferon-gamma combined with all-trans retinoic acid on proliferation and differentiation of leukemia cell lines NB4 and MR2]. He PC; Zhang M; Wu D; Xu H; Cai RB; Liu YL Ai Zheng; 2006 Dec; 25(12):1477-82. PubMed ID: 17166370 [TBL] [Abstract][Full Text] [Related]
8. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites. Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271 [TBL] [Abstract][Full Text] [Related]
9. WEB-2086 and WEB-2170 trigger apoptosis in both ATRA-sensitive and -resistant promyelocytic leukemia cells and greatly enhance ATRA differentiation potential. Laurenzana A; Cellai C; Vannucchi AM; Pancrazzi A; Romanelli MN; Paoletti F Leukemia; 2005 Mar; 19(3):390-5. PubMed ID: 15674364 [TBL] [Abstract][Full Text] [Related]
11. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells. Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153 [TBL] [Abstract][Full Text] [Related]
12. Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death. Pendino F; Dudognon C; Delhommeau F; Sahraoui T; Flexor M; Bennaceur-Griscelli A; Lanotte M; Ségal-Bendirdjian E Oncogene; 2003 Dec; 22(57):9142-50. PubMed ID: 14668795 [TBL] [Abstract][Full Text] [Related]
13. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells. Falanga A; Consonni R; Marchetti M; Locatelli G; Garattini E; Passerini CG; Gordon SG; Barbui T Blood; 1998 Jul; 92(1):143-51. PubMed ID: 9639510 [TBL] [Abstract][Full Text] [Related]
14. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. Duprez E; Wagner K; Koch H; Tenen DG EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978 [TBL] [Abstract][Full Text] [Related]
15. Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2. Grolleau A; Wietzerbin J; Beretta L Leukemia; 2000 Nov; 14(11):1909-14. PubMed ID: 11069026 [TBL] [Abstract][Full Text] [Related]
16. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078 [TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells. Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639 [TBL] [Abstract][Full Text] [Related]
18. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction. Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein. Ng AP; Nin DS; Fong JH; Venkataraman D; Chen CS; Khan M Mol Cancer Ther; 2007 Aug; 6(8):2240-8. PubMed ID: 17699721 [TBL] [Abstract][Full Text] [Related]
20. NLS-RARα Inhibits the Effects of All-trans Retinoic Acid on NB4 Cells by Interacting with P38α MAPK. Xiao C; Zhong L; Shan Z; Xu T; Gan L; Song H; Yang R; Li L; Liu B Int J Med Sci; 2016; 13(8):611-9. PubMed ID: 27499693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]